Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Sodium orthovanadate treatment inhibits caspase-3 activation induced by ischemia
Chemical Name: 13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9
contractions induced by AII 3×10-8 M do not differ in untreated spontaneously hypertensive rats (SHR) and WKY
67% in Miapaca-2 cells and from 29
reaching a maximum in the 3 mg/kg/day dose group of 70% above vehicle in the initial efflux rate
Orexin 2 Receptor Agonist Size:Contact [email protected] for quotation Sodium orthovanadate treatment inhibits caspase-3Orexin 2 Receptor Agonist is a potent (EC50 on OX2R is 23 nM) and OX2R selective (OX1R OX2R EC50 ratio is 70) agonist. IC50 value: 23 nM (EC50)Target: Orexin 2 ReceptorOrexin 2 Receptor Agonist shows not only potentactivity but also high selectivity for OX2R over OX1R. In CHO cells overexpressing hOX1R and HEK 293 cells overexpressing hOX2R, compound 26 displaced [125I]orexin A in a concentration dependent manner: 26 bound to hOX2R and hOX1R with Ki
US$ 85.90
US$ 165.50
US$ 10.25